Please login to the form below

Not currently logged in
Email:
Password:

ABPI revises UK Code Of Practice

The Association of British the Pharmaceutical Industry has revealed it will revise its Code of Practice, following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations.

The Association of British the Pharmaceutical Industry (ABPI) has revealed it will revise its Code of Practice, following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations.

The ABPI code oversees the activities of UK-based pharmaceutical companies and their employees. It is also required to include all the provisions of the code administered by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The ABPI and other national trade associations in Europe have been cooperating with EFPIA to develop and draft the new code. Most of the new provisions are already covered by the existing ABPI code, but those covering aspects of companies' relationships with patient organisations, must incorporate the new EFPIA rules.

The deadline for the implementation of the new changes is 1 July 2008. For example, companies will now have to include a short description of the nature of the support provided to patient organisations. Also, indirect financial backing and indirect, non-financial support will also need to be declared.

Nigel Brooksby, President of the ABPI, said: "Our code is one of the most rigorous in the world, and it is reviewed every two to three years to ensure that it remains fit for purpose. As well as taking on board the comparatively small number of changes that the new European patient code makes necessary, we shall be looking at including any suggested alterations identified during the life of the current code."

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics